1. Home
  2. STVN vs TMHC Comparison

STVN vs TMHC Comparison

Compare STVN & TMHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STVN
  • TMHC
  • Stock Information
  • Founded
  • STVN 1949
  • TMHC 1936
  • Country
  • STVN Italy
  • TMHC United States
  • Employees
  • STVN N/A
  • TMHC N/A
  • Industry
  • STVN Containers/Packaging
  • TMHC Homebuilding
  • Sector
  • STVN Consumer Discretionary
  • TMHC Consumer Discretionary
  • Exchange
  • STVN Nasdaq
  • TMHC Nasdaq
  • Market Cap
  • STVN 6.6B
  • TMHC 6.1B
  • IPO Year
  • STVN 2021
  • TMHC 2013
  • Fundamental
  • Price
  • STVN $24.88
  • TMHC $62.65
  • Analyst Decision
  • STVN Buy
  • TMHC Buy
  • Analyst Count
  • STVN 5
  • TMHC 8
  • Target Price
  • STVN $25.70
  • TMHC $75.63
  • AVG Volume (30 Days)
  • STVN 251.5K
  • TMHC 1.2M
  • Earning Date
  • STVN 08-05-2025
  • TMHC 07-23-2025
  • Dividend Yield
  • STVN 0.25%
  • TMHC N/A
  • EPS Growth
  • STVN N/A
  • TMHC 23.02
  • EPS
  • STVN 0.50
  • TMHC 8.60
  • Revenue
  • STVN $1,215,562,040.00
  • TMHC $8,364,403,000.00
  • Revenue This Year
  • STVN $8.69
  • TMHC N/A
  • Revenue Next Year
  • STVN $10.67
  • TMHC $0.92
  • P/E Ratio
  • STVN $51.37
  • TMHC $7.29
  • Revenue Growth
  • STVN 3.81
  • TMHC 12.19
  • 52 Week Low
  • STVN $17.12
  • TMHC $51.90
  • 52 Week High
  • STVN $26.50
  • TMHC $75.49
  • Technical
  • Relative Strength Index (RSI)
  • STVN 52.29
  • TMHC 53.05
  • Support Level
  • STVN $24.71
  • TMHC $61.60
  • Resistance Level
  • STVN $26.50
  • TMHC $65.23
  • Average True Range (ATR)
  • STVN 1.08
  • TMHC 2.02
  • MACD
  • STVN -0.03
  • TMHC -0.22
  • Stochastic Oscillator
  • STVN 43.36
  • TMHC 31.90

About STVN Stevanato Group S.p.A.

Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.

About TMHC Taylor Morrison Home Corporation

Taylor Morrison Home Corp is an American residential construction company engaged in residential homebuilding and the development of lifestyle communities. It designs, builds, and sells single and multi-family detached and attached homes in traditionally high growth markets for entry level, move-up, and resort lifestyle buyers. The company has four reportable segments: East, Central, West, and Financial Services. The majority of the company's revenue is derived from its West Segment.

Share on Social Networks: